Details of the Drug

General Information of Drug (ID: DMSWUNX)

Drug Name
Naratuximab emtansine
Synonyms DEBIO 1562
Indication
Disease Entry ICD 11 Status REF
Diffuse large B-cell lymphoma 2A81 Phase 2 [1]
Non-hodgkin lymphoma 2B33.5 Phase 2 [1]
Drug Type
Antibody
Cross-matching ID
DrugBank ID
DB15453
TTD ID
D2R0UM
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leukocyte antigen CD37 (CD37) TTFCW29 CD37_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02564744) Study to Evaluate the Efficacy and Tolerability Debio 1562 in Combination With Rituximab in Patients With Relapsed and/or Refractory DLBCL and Other Forms of NHL. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Debiopharm.